Treatment of antiretroviral-drug-resistant HIV-1 infection
- 1 December 2003
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 362 (9400) , 2002-2011
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Treatment with Indinavir, Efavirenz, and Adefovir after Failure of Nelfinavir TherapyThe Journal of Infectious Diseases, 2003
- Viral breakthrough after suppression with highly active antiretroviral therapyAIDS, 2003
- Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*Annals of Internal Medicine, 2002
- Amprenavir Inhibitory Quotient and Virological Response in Human Immunodeficiency Virus-Infected Patients on an Amprenavir-Containing Salvage Regimen without or with RitonavirAntimicrobial Agents and Chemotherapy, 2002
- CD4+T Cell Kinetics and Activation in Human Immunodeficiency Virus–Infected Patients Who Remain Viremic Despite Long‐Term Treatment with Protease Inhibitor–Based TherapyThe Journal of Infectious Diseases, 2002
- Twice‐Daily Triple Nucleoside Intensification Treatment with Lamivudine‐Zidovudine plus Abacavir Sustains Suppression of Human Immunodeficiency Virus Type 1: Results of the TARGET StudyThe Journal of Infectious Diseases, 2001
- Intensification of stable background therapy with abacavir in antiretroviral therapy experienced patients: 48-week data from a randomized, double-blind trialHIV Medicine, 2001
- Randomized Study of Saquinavir with Ritonavir or Nelfinavir Together with Delavirdine, Adefovir, or Both in Human Immunodeficiency Virus–Infected Adults with Virologic Failure on Indinavir: AIDS Clinical Trials Group Study 359The Journal of Infectious Diseases, 2000
- In Vivo Antagonism with Zidovudine plus Stavudine Combination TherapyThe Journal of Infectious Diseases, 2000
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996